免責聲明
本網站僅提供窩客幫資訊參考平台, 並不涉入其中任何諮詢、交易。本網站對各該窩客幫相關資訊亦不作任何實質或形式上之審查。本網站中所載一切窩客幫的資訊、文字、照片、圖形 、產權、廣告內容、或其他資料(以下簡稱『內容』)。無論其為公開張貼或私下傳送,若有不實或違法情事,均為『內容』提供者之責任,窩客幫概不負責也不承擔任何法律責任。
研究圖書館
PE0301
Totipro® PE0301

PE0301 Patent Portfolio

Intellectual property protection for heat-inactivated Lactobacillus paracasei PE0301 compositions and applications in oral care, microbiome modulation, and mucosal immunity.
 
  • 2
    PE0301 Patents
  • 2
    Granted
  • 0
    Pending/Published
  • NaN
    Total Citations
  • Granted
  • USPTO
  • Oral Care
Composition Including Probiotics and Method of Increasing Amount of Oral Immunoglobuling A and Inhibiting Oral Pathogens by Administering the Sam
  • US-11759487-B2
  • Applied: 2021
  • Granted: 2023
  • Citations
  • In Force
 
Technical Field
Oral care, postbiotics, antimicrobial compositions, oral microbiome modulation
  •  
    Background
    The human oral cavity hosts over ten thousand bacteria that digest sugars to form tenacious biofilms on teeth and periodontal tissues. Aerobic bacteria, such as Streptococcus mutans, erode tooth enamel by secreting acidic substances, leading to cavities. Meanwhile, anaerobic pathogens like Porphyromonas gingivalis release toxins that cause inflammation, bone damage, and bad breath. Since salivary immunoglobulin A (IgA) is critical for mucosal immunity and defending against these pathogens, there is a significant need for probiotic compositions that can effectively increase oral IgA levels and inhibit pathogen growth to maintain oral health.
  •  
    Summary of Invention
    The invention provides a method of increasing an amount of oral immunoglobulin A (IgA) and/or inhibiting oral pathogens in a subject in need thereof, which utilizes a composition including a therapeutically effective amount of probiotics as an effective ingredient. The probiotics include Lactobacillus plantarum LPL28, which can efficiently increase the amount of oral IgA and/or inhibit the oral pathogens, and thus have a potential to prevent teeth cavities and/or periodontal diseases.
  •  
    Key Claims
    •  
      Core Probiotic Strain: The patent protects a method of increasing oral IgA by administering a composition containing the specific strain Lactobacillus plantarum LPL28 (deposited under accession number CGMCC 17954).
    •  
      Synergistic Multi-Strain Combination: The scope includes the addition of other functional strains, specifically L. salivarius AP-32 and/or L. paracasei ET-66, to the LPL28 base.
    •  
      Three-Mixed Strain Method: A specific method is claimed for the combined administration of all three strains—LPL28, AP-32, and ET-66—to maximize the increase of IgA levels in a subject.
    •  
      Postbiotic/Heat-Kill Application: The claims explicitly cover probiotics that have been subjected to a heat-kill step or a combination of heat-kill and centrifugation, confirming that inactive bacterial cells (postbiotics) remain effective for this use.
    •  
      Diverse Product Formats: The protection extends to various delivery methods, including food compositions (dairy products, non-dairy beverages, or oral cleansing foods) and oral topical compositions (oral care products or breath-freshening agents).
Inventors
  • Ho; Hsieh-Hsun
  • Lin; Wen-Yang
  • Kuo; Yi-Wei
  • Huang; Yen-Yu
  • Lin; Jia-Hung
  • Lin; Chi-Huei
  • Liu; Cheng-Ruei
  • Chen; Shu-Hui
  • Granted
  • TIPO
  • Oral Care
提升口腔免疫球蛋白A含量及抑制口腔病原菌之組成物及其用途
  • I823060
  • Applied: 2021
  • Granted: 2023
  • Citations
  • In Force
 
Technical Field
Microbiome modulation, postbiotics, oral health, immunomodulation
  •  
    Background
    人類口腔中存在上萬種細菌,會消化糖分並形成生物膜 。其中需氧菌(如變形鏈球菌)會產生酸性物質侵蝕琺瑯質導致蛀牙 ;厭氧菌(如牙齦卟啉單胞菌)則會釋放毒素引發牙周組織發炎、腫脹及口臭 。由於口腔黏膜防禦高度仰賴免疫球蛋白 A(IgA),因此研發能有效增加 IgA 並抑制病原菌的組合物對於強化口腔免疫至關重要。
  •  
    Summary of Invention
    本發明提供一種益生菌用於製備提升口腔免疫球蛋白A含量及抑制口腔病原菌之組成物的用途,其中此益生菌包含植物乳酸桿菌(Lactobacillus plantarum) LPL28做為有效成分,可有效提升口腔 IgA 含量及/或抑制口腔病原菌,而具有預防龋齒及/或牙周病的潛力。
  •  
    Key Claims
    •  
      核心菌株應用:提出一種增加口腔 IgA 的方法,其核心在於投與含有 植物乳桿菌 LPL28(寄存編號 CGMCC 17954)的組合物 。
    •  
      多菌株組合:組合物可進一步包含 唾液乳酸桿菌 AP-32 及 副乾酪乳桿菌 ET-66,以協同強化功效 。
    •  
      三菌組合專利:明確保護 LPL28、AP-32 與 ET-66 三株特定菌株組合的使用方法 。
    •  
      類生質(Postbiotics)技術:權利要求中涵蓋了將益生菌進行 熱滅活處理(Heat-kill) 及其離心步驟後之應用,代表死菌亦具備增加 IgA 之功能 。
    •  
      多元產品型態:組合物可廣泛應用於 食品(如乳製品、清潔口腔之食品)或 口腔局部護理產品(如牙膏、漱口水、噴劑)中 。
Inventors
  • 何協勳
  • 林文揚
  • 郭易緯
  • 黃彥字
  • 林家弘
  • 林杞輝
  • 劉承叡
  • 陳淑慧
相關文章
電話 : 065891876 地址 : 台南市新市區台南市新市區國際路17號4樓之2

  • 服務項目

  • 特別關鍵字